BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 29691971)

  • 1. Hydroxychloroquine may be associated with reduced risk of coronary artery diseases in patients with rheumatoid arthritis: A nationwide population-based cohort study.
    Hung YM; Wang YH; Lin L; Wang PYP; Chiou JY; Wei JC
    Int J Clin Pract; 2018 May; 72(5):e13095. PubMed ID: 29691971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination effect of anti-rheumatic medications for coronary artery diseases risk in rheumatoid arthritis: a nationwide population-based cohort study.
    Hung YM; Lin L; Wang YH; Wei JC; Wang PY; Chiou JY
    Curr Med Res Opin; 2019 Feb; 35(2):313-320. PubMed ID: 29939099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study.
    Lo CH; Wei JC; Wang YH; Tsai CF; Chan KC; Li LC; Lo TH; Su CH
    Front Immunol; 2021; 12():631869. PubMed ID: 33868251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients.
    Sharma TS; Wasko MC; Tang X; Vedamurthy D; Yan X; Cote J; Bili A
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26727968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine was associated with reduced risk of new-onset diabetes mellitus in patients with Sjögren syndrome.
    Chen TH; Lai TY; Wang YH; Chiou JY; Hung YM; Wei JC
    QJM; 2019 Oct; 112(10):757-762. PubMed ID: 31218368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of anti-rheumatic medications for coronary artery diseases risk in patients with rheumatoid arthritis might be changed over time: A nationwide population-based cohort study.
    Hung YM; Lin L; Chen CM; Chiou JY; Wang YH; Wang PY; Wei JC
    PLoS One; 2017; 12(6):e0179081. PubMed ID: 28658301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxychloroquine is neutral on incidental cataracts in patients with rheumatoid arthritis.
    Zhang Z; Ma X; Wang YH; Shi X; Wei JC
    Sci Rep; 2023 Apr; 13(1):5576. PubMed ID: 37019978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications.
    Kerr G; Aujero M; Richards J; Sayles H; Davis L; Cannon G; Caplan L; Michaud K; Mikuls T
    Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1619-26. PubMed ID: 24692402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine use is associated with reduced mortality risk in older adults with rheumatoid arthritis.
    Iyer P; Gao Y; Jalal D; Girotra S; Singh N; Vaughan-Sarrazin M
    Clin Rheumatol; 2024 Jan; 43(1):87-94. PubMed ID: 37498463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.
    Chen YM; Lin CH; Lan TH; Chen HH; Chang SN; Chen YH; Wang JS; Hung WT; Lan JL; Chen DY
    Rheumatology (Oxford); 2015 Jul; 54(7):1244-9. PubMed ID: 25587177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of coronary artery disease in patients with rheumatoid arthritis using Chinese herbal products and conventional medicine in parallel: a population-based cohort study.
    Yu HH; Hsiung NH; Chiang JH; Shen HS
    BMC Complement Med Ther; 2020 Mar; 20(1):100. PubMed ID: 32228568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
    Karlsson JA; Neovius M; Nilsson JÅ; Petersson IF; Bratt J; van Vollenhoven RF; Ernestam S; Geborek P
    Ann Rheum Dis; 2013 Dec; 72(12):1927-33. PubMed ID: 23196701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term hydroxychloroquine on vascular events in patients with systemic lupus erythematosus: a database prospective cohort study.
    Hsu CY; Lin YS; Su YJ; Lin HF; Lin MS; Syu YJ; Cheng TT; Yu SF; Chen JF; Chen TH
    Rheumatology (Oxford); 2017 Dec; 56(12):2212-2221. PubMed ID: 29029334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular Safety of Hydroxychloroquine in US Veterans With Rheumatoid Arthritis.
    Faselis C; Zeng-Treitler Q; Cheng Y; Kerr GS; Nashel DJ; Liappis AP; Weintrob AC; Karasik PE; Arundel C; Boehm D; Heimall MS; Connell LB; Taub DD; Shao Y; Redd DF; Sheriff HM; Zhang S; Fletcher RD; Fonarow GC; Moore HJ; Ahmed A
    Arthritis Rheumatol; 2021 Sep; 73(9):1589-1600. PubMed ID: 33973403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate might reduce ischemic stroke in patients with rheumatoid arthritis: a population-based retrospective cohort study.
    Tam HW; Chen CM; Leong PY; Chen CH; Li YC; Wang YH; Lin LC; Chiou JY; Wei JC
    Int J Rheum Dis; 2018 Aug; 21(8):1591-1599. PubMed ID: 29372595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Risk of Chronic Kidney Disease in Rheumatoid Arthritis Associated with Cardiovascular Complications - A National Population-Based Cohort Study.
    Chiu HY; Huang HL; Li CH; Chen HA; Yeh CL; Chiu SH; Lin WC; Cheng YP; Tsai TF; Ho SY
    PLoS One; 2015; 10(9):e0136508. PubMed ID: 26406879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Temporomandibular Disorders in Rheumatoid Arthritis and Associated Risk Factors: A Nationwide Study in Taiwan.
    Lin CY; Chung CH; Chu HY; Chen LC; Tu KH; Tsao CH; Wu YT; Chien WC
    J Oral Facial Pain Headache; 2017 Fall; 31(4):e29-e36. PubMed ID: 29073669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis.
    Rempenault C; Combe B; Barnetche T; Gaujoux-Viala C; Lukas C; Morel J; Hua C
    Ann Rheum Dis; 2018 Jan; 77(1):98-103. PubMed ID: 28970215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hydroxychloroquine pre-exposure on infection with SARS-CoV-2 in rheumatic disease patients: a population-based cohort study.
    Jung SY; Kim MS; Kim MC; Choi SH; Chung JW; Choi ST
    Clin Microbiol Infect; 2021 Apr; 27(4):611-617. PubMed ID: 33316402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Hydroxychloroquine and bacterial pneumonia in rheumatic patients: A population-based propensity score matching cohort study.
    Lin SY; Lin CL; Chang SS; Hsu WH; Lin CC; Kao CH
    Int J Clin Pract; 2021 Nov; 75(11):e14737. PubMed ID: 34388303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.